Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Candel Therapeutics, Inc. | Chief Scientific Officer | Common Stock | 160K | $1.04M | $6.47 | Jul 17, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CADL | Candel Therapeutics, Inc. | Jul 17, 2024 | 1 | -$90.9K | 4 | Jul 19, 2024 | Chief Scientific Officer |
CADL | Candel Therapeutics, Inc. | Jul 11, 2024 | 1 | -$75.5K | 4 | Jul 15, 2024 | Chief Scientific Officer |
CADL | Candel Therapeutics, Inc. | Nov 28, 2023 | 1 | -$17.8K | 4 | Nov 30, 2023 | Chief Scientific Officer |
CADL | Candel Therapeutics, Inc. | Nov 26, 2023 | 1 | $0 | 4 | Nov 28, 2023 | Chief Scientific Officer |
CADL | Candel Therapeutics, Inc. | Apr 28, 2023 | 1 | $0 | 4 | May 2, 2023 | Chief Scientific Officer |
CADL | Candel Therapeutics, Inc. | Dec 8, 2022 | 1 | $1.99K | 4 | Dec 12, 2022 | Chief Scientific Officer |
CADL | Candel Therapeutics, Inc. | Nov 28, 2022 | 1 | $0 | 4 | Nov 30, 2022 | Chief Scientific Officer |
CADL | Candel Therapeutics, Inc. | Feb 28, 2022 | 1 | $0 | 4 | Mar 1, 2022 | Chief Scientific Officer |
CADL | Candel Therapeutics, Inc. | Feb 3, 2022 | 1 | $0 | 4 | Feb 7, 2022 | Chief Scientific Officer |
CADL | Candel Therapeutics, Inc. | Feb 3, 2022 | 0 | $0 | 3 | Feb 7, 2022 | Chief Scientific Officer |